Each AHSN issues challenges in response to defined NHS needs. They describe the needs of the NHS in a local or national context and are shown on the AHSN page. They set out the market opportunity for an innovator – you can also view all challenges across the AHSN network.
Find your nearest AHSN
Developing partnerships for NHSx AI Award applications
The Artificial Intelligence (AI) in Health and Care Award aims to benefit patients by combining the power of artificial intelligence with the expertise of the NHS to improve health and care outcomes. The Award is making £140 million available over four years to accelerate the testing and evaluation of technologies most likely to meet the aims set out in the NHS Long Term Plan. Each round of the Award supports technologies at different levels of maturity, targeting health and care improvements where they are needed most, by both patients and NHS staff. These competitions have been designed to support innovators and technologies across the spectrum of development - from concept through to initial NHS adoption and testing of the AI technology within clinical pathways
WMAHSN Atlas of Good Practice for Equality, Diversity and Inclusion
The WMAHSN Atlas of Good Practice for Equality, Diversity and Inclusion (E, D & I) is an online resource that shares examples from across the West Midlands of how to build E, D & I into a healthcare related project or solution.
Support for Rapid Uptake Product - FeNO Testing - 2021/22
The Accelerated Access Collaborative at NHS England and Improvement has been working with the AHSN Network to roll out FeNO testing to help improve the diagnosis of asthma.
Supporting the recovery of elective care
Innovation Exchange - Digital technology to support clinically led, patient focused reviews and validation of waiting lists for elective inpatient, outpatient and diagnostic services for adults and children (including specialised services). Addressing elective care waiting lists, enabling patients to live healthier lives, is one of the NHS’ top priorities for 2021/22. Following the impact of the COVID19 pandemic, significant progress has been achieved by the NHS to meet elective targets.
Digital technology for people with learning disabilities to support happier, healthier lives
The Learning Disability Mortality Review (LeDeR) programme and longstanding reports provide evidence that the signs of health deterioration are not always detected promptly by support workers and, furthermore, that concerns expressed by support workers to health professionals are not always taken seriously or responded to in ways that maximise the potential for good health outcomes. As such, people with a Learning Disability die prematurely with conditions that could have been prevented or amenable to treatment, with commonly occurring causes of death including pneumonia, aspiration pneumonia, sepsis, ischaemic heart disease and epilepsy. There are also a concerning number of deaths due to constipation.
Domiciliary care search for innovations - £100k funding for pilots
The West of England AHSN, South West AHSN and Health Education England South West, are launching an important challenge to find innovative solutions to support the domiciliary social and health care workforce, with £100,000 funding available for pilots in the region. They are looking for innovators from across the country to apply to help in the region.
Innovation call to address LGBT+ health inequalities
The AHSN Network and LGBT Foundation have joined forces to launch a nationwide call for innovations to help address health inequalities facing lesbian, gay, bisexual and trans (LGBT) people, many of which have been exacerbated by COVID-19. These challenges are highlighted in our new compilation of evidence of LGBT+ health inequalities. From MedTech and digital apps to improvement programmes, changes in practice and new pathways, we are looking for innovations and innovative approaches already in use or in development. Ground-breaking and inspiring examples of work in this area will be showcased in a report to be published later this year by the AHSN Network and LGBT Foundation, which we hope will support best practice to be spread more widely across health and care services.
Improving detection and management of high cholesterol to prevent cardiovascular disease
Cholesterol-lowering treatment is an effective intervention for the primary and secondary prevention of cardiovascular conditions, such as stroke and myocardial infarction (commonly known as a heart attack). However, many people are unaware they have high cholesterol, or receive sub-optimal treatment for it.